Vitamin E TPGS combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glycoprotein mediated drug efflux and other mechanisms which reduce first-pass metabolism and facilitate its transport, cell uptake and function. The safety and efficacy of TPGS expanded research and development in major areas.

EFSA conducted scientific evaluation of the safety of Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) in its review of a food additive application, supported by Antares Health Products, Inc. (Antares). In its report, published in the EFSA Journal, the Scientific Panel concluded that the use of Vitamin E TPGS as a new food additive does not raise a safety concern at the proposed use and use levels.

Antares Health Products, Inc. can help you in bringing all the benefits of Antares Vitamin E TPGS into value-added ingredients and formulations for the dietary supplement, food and beverage, and animal nutrition markets.

Antares continued its decade long record of meeting customer needs without a single out-of-stock event despite the challenges of the coronavirus pandemic.

Antares Health Products is increasing production, distribution, and customer service to meet the increasing international demand for its Vitamin E TPGS.

Antares Health Products further enhances its high quality customer and technical service.